Showing results (261-270 of 340) with videos related to
Sort By:
Pageof 34
Trends in Cardiovascular Medicine|January 15, 2011
Generation of transgenic mice from yeast artificial chromosome DNA that has been modified by gene targetingS P McCormick, K R Peterson, R E Hammer, et al.The Biochemical Journal|October 8, 1999
Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient miceH R Jung, S M Turner, R A Neese, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 1, 1975
7-Amino-actinomycin D as a cytochemical probe. I. Spectral propertiesJ E Gill, M M Jotz, S G Young, et al.Arteriosclerosis (Dallas, Tex.)|May 1, 1990
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoproteinW Palinski, S Ylä-Herttuala, M E Rosenfeld, et al.The Journal of Clinical Investigation|June 1, 1987
Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100S G Young, S J Bertics, L K Curtiss, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein BS G Young, S J Bertics, L K Curtiss, et al.Journal of Lipid Research|August 26, 1998
Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiencyR L Hamilton, J S Wong, C M Cham, et al.Journal of Lipid Research|February 1, 1989
Colestipol-induced changes in LDL composition and metabolism. II. Studies in humansS G Young, J L Witztum, T E Carew, et al.Clinical Chemistry|August 1, 1986
Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein BS G Young, R S Smith, D M Hogle, et al.The Journal of Clinical Investigation|March 1, 1990
Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteinsS G Young, S T Hubl, R S Smith, et al.Pageof 34